Articles & Video
The Future of the Biopharmaceutical Industry
What will the biopharmaceutical industry look like 10 years from now? In an interactive ebook, we look at the biggest outcomes, opportunities and challenges likely to arise.
BioProcess International | BioProcess Insider
BioProcess International is a monthly, controlled-circulation magazine devoted to the development, scale-up, and manufacture of biotherapeutics and biodiagnostics.
Formulation, Fill, Finish — Biopharmaceutical Drug Products for a Modern Age
This BioProcess International eBook highlights drug-product formulation concerns and collaborative efforts toward solving the fill–finish conundrum.
Automating cell and gene therapy manufacturing: challenges and approaches
With the pressure on to scale up manufacturing of cell and gene therapies, what steps should organizations take to optimize their processes with automation? We asked three industry experts for their advice.
42% of pharma industry believe cell and gene therapies to be most promising therapeutics
According to a recent study, 42% of pharma industry professionals predict cell and gene therapies are the therapeutic area that will see the fastest growth in the next 10 years.
Cell and Gene Therapy Report 2020: Viral and Non-viral Vectors
This report of our recent global industry survey reveals the biggest challenges in viral and non-viral vector manufacturing for cell and gene therapies.
Peptide Therapies — Small Biomolecules Address Big Health Problems
This BioProcess International ebook looks at product research, manufacturing and regulatory concerns within the promising world of peptide therapies.
Pharma R&D Annual Review 2020
The researchers and analysts at Pharma Intelligence have taken the guess work out of figuring out how pharmaceutical research and development has progressed over the past few years and what you can expect in 2020. Pharma R&D Annual Review 2020 condenses the thorough analysis of all drugs in development by pharmaceutical companies, from those at the preclinical stage, through the various stages of clinical testing and regulatory approval, and up to and including launch.
Standardizing microbiome therapeutics: Strategies for defining manufacturing protocols
We identify the available strategies microbiome companies can take to define standards for manufacturing therapeutic products.
Interview- Roche’s approach to drug discovery, innovation and meeting patients' needs
James Sabry, Global Head of Roche Pharma Partnering, discusses Roche’s approach to discovering scientific breakthroughs, accelerating innovative research, collaborating with stakeholders, and meeting unmet medical needs in China and around the world.
80% of life sciences professionals predict a COVID-19 vaccine will be approved within 18 months
How quickly to life sciences professionals predict a COVID-19 vaccine will be approved and what are the main obstacles? We explore.
The biggest breakthroughs in life sciences the last 10 years
CRISPR, CAR-T, immunotherapies, genome sequencing, AI - what is the biggest breakthrough in the life sciences in the last 10 years?
Strategies to Innovate the Production of Next Generation Bioconjugates
From developing ADCs to tumor-targeting, this whitepaper reviews the latest common challenges and novel strategies for producing bioconjugates.
Future Trends in Proteins To Fight COVID-19
The whitepaper presents new case studies exposing the growing opportunities in protein therapeutics to treat COVID-19.
Gene-Edited Cell Therapies: CMC Challenges and Considerations - WHITEPAPER
This whitepaper reviews the current challenges in manufacturing gene-edited cell therapies and ways to approach them, presenting key case studies.
Technologies and Novel Platforms for Optimizing Cell and Gene Therapies
This interactive ebook explores the unique challenges in the cell and gene therapy industry which are being solved by emerging technology and platforms.
Diversity in the life sciences workplace: Implementing a leading corporate culture for innovation - WHITEPAPER
This paper looks at how to foster racial, gender, geographical, neuro and cognitive diversity in the life sciences to achieve an inclusive culture built for innovation.
REPORT: Antibody Therapeutic Modalities 2020
Global research study into the development, targets, challenges and technologies of different antibody therapeutic modalities.
REPORT: Diversity, Inclusion and Sustainability in the Global Life Sciences Industry 2020
Diversity and Inclusion in Life Sciences 2020: Research analysis of how life sciences professionals around the world view representation of women and minorities in the industry, plus the importance of sustainability.
Innovating CMC for Oligonucleotide and Peptide Therapeutics
In a new ebook, we look at ways to optimize chemistry manufacturing and controls for oligonucleotide and peptide therapeutics.
BioProcess International Spring Digital Week 2020 agenda revealed
We reveal the sessions of the upcoming 7-day webinar series on innovating biopharmaceutical development and production.